Dr Fields collaborates with Dr Luis Raez to submit a re-accreditation application after four years.
The center sees significant advancements in patient treatment, clinical trials, and grant funding, securing 4.2 million through collaborative proposals. Increased collaboration leads to diverse patient populations, and a biorepository is developed to analyze cancer treatment samples.

Research focuses on the MBLAC1 protein, enhancing understanding of drug effectiveness and guiding clinical trials.